The University of Missouri Research Reactor (MURR) has successfully delivered its first batch of no-carrier-added lutetium-177 (NCA Lu-177) for cancer treatment. The weekly shipments are being ...
The MU Research Reactor facility, known as MURR, is the only manufacturer in the nation to produce lifesaving treatments for liver, pancreatic, thyroid and prostate cancers. The $20 million ...